Devon Glynn, FNP-BC - Medicare Nurse Practitioner in Denver, CO

Devon Glynn, FNP-BC is a medicare enrolled "Nurse Practitioner - Family" in Denver, Colorado. His current practice location is 255 N Washington St Unit 205, Denver, Colorado. You can reach out to his office (for appointments etc.) via phone at (941) 447-7646.

Devon Glynn is licensed to practice in Colorado (license number APN.0996129-NP) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1013503572.

Contact Information

Devon Glynn, FNP-BC
255 N Washington St Unit 205,
Denver, CO 80203-4280
(941) 447-7646
Not Available



Provider's Profile

Full NameDevon Glynn
GenderMale
SpecialityNurse Practitioner - Family
Location255 N Washington St Unit 205, Denver, Colorado
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1013503572
  • Provider Enumeration Date: 12/17/2020
  • Last Update Date: 10/22/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 2769895465
  • Enrollment ID: I20210119000133

Medical Identifiers

Medical identifiers for Devon Glynn such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013503572NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family APN.0996129-NP (Colorado)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Devon Glynn allows following entities to bill medicare on his behalf.
Entity NameMedventures, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1194972042
PECOS PAC ID: 1850440652
Enrollment ID: O20090528000096

News Archive

Unique 'Golden Hour' study details ultra-early immune response to trauma

Scientists from the University of Birmingham are carrying out pioneering research as part of a major £10 million study aimed at improving outcomes for patients who have suffered a traumatic injury.

TUM scientists develop small molecule that may allow future patient-specific treatment of cancer tumours

Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now scientists at the Technical University of Munich have successfully developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer.

ESMO drives collaborative action at EU level to address essential medicine shortages

Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes. ISIS 113715 is a novel insulin sensitizer that reduces the expression of protein tyrosine phosphatase-1B (PTP-1B). The study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

Sleep studies may be an unreliable predictor for treatment of children with sleep apnea

Pediatricians routinely advise parents of children who snore regularly and have sleepiness, fatigue or other symptoms consistent with sleep disordered breathing, to get a sleep study; this can help determine whether their child has obstructive sleep apnea, which is often treated with surgery to remove the tonsils and adenoids (adenotonsillectomy).

Read more Medical News

› Verified 1 days ago

Entity NameJg Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881101640
PECOS PAC ID: 3577824838
Enrollment ID: O20180301000081

News Archive

Unique 'Golden Hour' study details ultra-early immune response to trauma

Scientists from the University of Birmingham are carrying out pioneering research as part of a major £10 million study aimed at improving outcomes for patients who have suffered a traumatic injury.

TUM scientists develop small molecule that may allow future patient-specific treatment of cancer tumours

Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now scientists at the Technical University of Munich have successfully developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer.

ESMO drives collaborative action at EU level to address essential medicine shortages

Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes. ISIS 113715 is a novel insulin sensitizer that reduces the expression of protein tyrosine phosphatase-1B (PTP-1B). The study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

Sleep studies may be an unreliable predictor for treatment of children with sleep apnea

Pediatricians routinely advise parents of children who snore regularly and have sleepiness, fatigue or other symptoms consistent with sleep disordered breathing, to get a sleep study; this can help determine whether their child has obstructive sleep apnea, which is often treated with surgery to remove the tonsils and adenoids (adenotonsillectomy).

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Devon Glynn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Devon Glynn, FNP-BC
1805 Shea Center Dr Ste 301,
Highlands Ranch, CO 80129-2277

Ph: (303) 814-0505
Devon Glynn, FNP-BC
255 N Washington St Unit 205,
Denver, CO 80203-4280

Ph: (941) 447-7646

News Archive

Unique 'Golden Hour' study details ultra-early immune response to trauma

Scientists from the University of Birmingham are carrying out pioneering research as part of a major £10 million study aimed at improving outcomes for patients who have suffered a traumatic injury.

TUM scientists develop small molecule that may allow future patient-specific treatment of cancer tumours

Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now scientists at the Technical University of Munich have successfully developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer.

ESMO drives collaborative action at EU level to address essential medicine shortages

Shortages of essential cancer medicines have a direct impact on patient care across Europe. To ensure that this issue remains a top priority on the EU policy agenda, ESMO -the leading European professional organization for medical oncology, collaborated with the European Parliament to organize a cross-partisan event entitled "Shortages of Inexpensive, Essential Medicines: Calling for Tangible Political Commitments in the EU".

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes. ISIS 113715 is a novel insulin sensitizer that reduces the expression of protein tyrosine phosphatase-1B (PTP-1B). The study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

Sleep studies may be an unreliable predictor for treatment of children with sleep apnea

Pediatricians routinely advise parents of children who snore regularly and have sleepiness, fatigue or other symptoms consistent with sleep disordered breathing, to get a sleep study; this can help determine whether their child has obstructive sleep apnea, which is often treated with surgery to remove the tonsils and adenoids (adenotonsillectomy).

Read more News

› Verified 1 days ago


Nurse Practitioner Nurses in Denver, CO

Ms. Kiok Cho, ANP-BC
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 55 Madison St Ste 355, Denver, CO 80206
Phone: 303-377-2020    
Barbara E Anderson, NP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 777 Bannock St, Denver, CO 80204
Phone: 303-602-8000    
Suzanne Marie Ehler, FNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 2045 N Franklin St, Denver, CO 80205
Phone: 303-338-4545    
Sumy Anthony, CERTIFIED NP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1601 E 19th Ave Ste 5050, Denver, CO 80218
Phone: 720-754-2155    Fax: 720-754-2106
Ashley Ann Zimbler,
Nurse Practitioner
Medicare: May Accept Medicare Assignments
Practice Location: 2810 Quebec St, Denver, CO 80207
Phone: 303-370-5870    
Mrs. Elisha Elizabeth Mcguire, CPNP-AC
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 2055 N High St Ste 270, Denver, CO 80205
Phone: 303-301-9010    
Kelsey Lee Swanson,
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1532 Dahlia St, Denver, CO 80220
Phone: 702-274-9199    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.